Technologies
A Business Review Of Spero Therapeutics Inc (NASDAQ: SPRO) And Growth Forecast
In today’s recent session, 123.98 million shares of the Spero Therapeutics Inc (NASDAQ:SPRO) have been traded, and its beta is 0.25. Most recently the company’s